Assessing craving and its relationship to subsequent prescription opioid use among treatment-seeking prescription opioid dependent patients
• Drug craving predicts future drug use, especially in the short term. • A 3-item measure predicted prescription opioid use in the next week. • For each 1 unit increase on the scale, the odds of using opioid was 17% higher. • Brief assessment of prescription opioid craving may provide a marker of ri...
Ausführliche Beschreibung
Autor*in: |
McHugh, R. Kathryn [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2014 |
---|
Schlagwörter: |
---|
Umfang: |
6 |
---|
Übergeordnetes Werk: |
Enthalten in: Statistical analysis to identify biomarkers for safety - Clark, Matthew ELSEVIER, 2018, an international journal on biomedical and psychosocial approaches, Amsterdam [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:145 ; year:2014 ; day:1 ; month:12 ; pages:121-126 ; extent:6 |
Links: |
---|
DOI / URN: |
10.1016/j.drugalcdep.2014.10.002 |
---|
Katalog-ID: |
ELV017546443 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV017546443 | ||
003 | DE-627 | ||
005 | 20230623135328.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180602s2014 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.drugalcdep.2014.10.002 |2 doi | |
028 | 5 | 2 | |a GBVA2014012000016.pica |
035 | |a (DE-627)ELV017546443 | ||
035 | |a (ELSEVIER)S0376-8716(14)01847-X | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 610 | |
082 | 0 | 4 | |a 610 |q DE-600 |
082 | 0 | 4 | |a 610 |q VZ |
084 | |a 15,3 |2 ssgn | ||
084 | |a PHARM |q DE-84 |2 fid | ||
084 | |a 44.38 |2 bkl | ||
084 | |a 44.39 |2 bkl | ||
100 | 1 | |a McHugh, R. Kathryn |e verfasserin |4 aut | |
245 | 1 | 0 | |a Assessing craving and its relationship to subsequent prescription opioid use among treatment-seeking prescription opioid dependent patients |
264 | 1 | |c 2014 | |
300 | |a 6 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a • Drug craving predicts future drug use, especially in the short term. • A 3-item measure predicted prescription opioid use in the next week. • For each 1 unit increase on the scale, the odds of using opioid was 17% higher. • Brief assessment of prescription opioid craving may provide a marker of risk. | ||
650 | 7 | |a Cue-induced craving |2 Elsevier | |
650 | 7 | |a Buprenorphine |2 Elsevier | |
650 | 7 | |a Craving |2 Elsevier | |
650 | 7 | |a Prescription opioids |2 Elsevier | |
700 | 1 | |a Fitzmaurice, Garrett M. |4 oth | |
700 | 1 | |a Carroll, Kathleen M. |4 oth | |
700 | 1 | |a Griffin, Margaret L. |4 oth | |
700 | 1 | |a Hill, Kevin P. |4 oth | |
700 | 1 | |a Wasan, Ajay D. |4 oth | |
700 | 1 | |a Weiss, Roger D. |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Clark, Matthew ELSEVIER |t Statistical analysis to identify biomarkers for safety |d 2018 |d an international journal on biomedical and psychosocial approaches |g Amsterdam [u.a.] |w (DE-627)ELV000553670 |
773 | 1 | 8 | |g volume:145 |g year:2014 |g day:1 |g month:12 |g pages:121-126 |g extent:6 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.drugalcdep.2014.10.002 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a FID-PHARM | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OPC-PHA | ||
936 | b | k | |a 44.38 |j Pharmakologie |q VZ |
936 | b | k | |a 44.39 |j Toxikologie |q VZ |
951 | |a AR | ||
952 | |d 145 |j 2014 |b 1 |c 1201 |h 121-126 |g 6 | ||
953 | |2 045F |a 610 |
author_variant |
r k m rk rkm |
---|---|
matchkey_str |
mchughrkathrynfitzmauricegarrettmcarroll:2014----:sesncaigniseainhpousqetrsrpinpodsaogramnseigr |
hierarchy_sort_str |
2014 |
bklnumber |
44.38 44.39 |
publishDate |
2014 |
allfields |
10.1016/j.drugalcdep.2014.10.002 doi GBVA2014012000016.pica (DE-627)ELV017546443 (ELSEVIER)S0376-8716(14)01847-X DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl McHugh, R. Kathryn verfasserin aut Assessing craving and its relationship to subsequent prescription opioid use among treatment-seeking prescription opioid dependent patients 2014 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Drug craving predicts future drug use, especially in the short term. • A 3-item measure predicted prescription opioid use in the next week. • For each 1 unit increase on the scale, the odds of using opioid was 17% higher. • Brief assessment of prescription opioid craving may provide a marker of risk. Cue-induced craving Elsevier Buprenorphine Elsevier Craving Elsevier Prescription opioids Elsevier Fitzmaurice, Garrett M. oth Carroll, Kathleen M. oth Griffin, Margaret L. oth Hill, Kevin P. oth Wasan, Ajay D. oth Weiss, Roger D. oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:145 year:2014 day:1 month:12 pages:121-126 extent:6 https://doi.org/10.1016/j.drugalcdep.2014.10.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 145 2014 1 1201 121-126 6 045F 610 |
spelling |
10.1016/j.drugalcdep.2014.10.002 doi GBVA2014012000016.pica (DE-627)ELV017546443 (ELSEVIER)S0376-8716(14)01847-X DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl McHugh, R. Kathryn verfasserin aut Assessing craving and its relationship to subsequent prescription opioid use among treatment-seeking prescription opioid dependent patients 2014 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Drug craving predicts future drug use, especially in the short term. • A 3-item measure predicted prescription opioid use in the next week. • For each 1 unit increase on the scale, the odds of using opioid was 17% higher. • Brief assessment of prescription opioid craving may provide a marker of risk. Cue-induced craving Elsevier Buprenorphine Elsevier Craving Elsevier Prescription opioids Elsevier Fitzmaurice, Garrett M. oth Carroll, Kathleen M. oth Griffin, Margaret L. oth Hill, Kevin P. oth Wasan, Ajay D. oth Weiss, Roger D. oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:145 year:2014 day:1 month:12 pages:121-126 extent:6 https://doi.org/10.1016/j.drugalcdep.2014.10.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 145 2014 1 1201 121-126 6 045F 610 |
allfields_unstemmed |
10.1016/j.drugalcdep.2014.10.002 doi GBVA2014012000016.pica (DE-627)ELV017546443 (ELSEVIER)S0376-8716(14)01847-X DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl McHugh, R. Kathryn verfasserin aut Assessing craving and its relationship to subsequent prescription opioid use among treatment-seeking prescription opioid dependent patients 2014 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Drug craving predicts future drug use, especially in the short term. • A 3-item measure predicted prescription opioid use in the next week. • For each 1 unit increase on the scale, the odds of using opioid was 17% higher. • Brief assessment of prescription opioid craving may provide a marker of risk. Cue-induced craving Elsevier Buprenorphine Elsevier Craving Elsevier Prescription opioids Elsevier Fitzmaurice, Garrett M. oth Carroll, Kathleen M. oth Griffin, Margaret L. oth Hill, Kevin P. oth Wasan, Ajay D. oth Weiss, Roger D. oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:145 year:2014 day:1 month:12 pages:121-126 extent:6 https://doi.org/10.1016/j.drugalcdep.2014.10.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 145 2014 1 1201 121-126 6 045F 610 |
allfieldsGer |
10.1016/j.drugalcdep.2014.10.002 doi GBVA2014012000016.pica (DE-627)ELV017546443 (ELSEVIER)S0376-8716(14)01847-X DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl McHugh, R. Kathryn verfasserin aut Assessing craving and its relationship to subsequent prescription opioid use among treatment-seeking prescription opioid dependent patients 2014 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Drug craving predicts future drug use, especially in the short term. • A 3-item measure predicted prescription opioid use in the next week. • For each 1 unit increase on the scale, the odds of using opioid was 17% higher. • Brief assessment of prescription opioid craving may provide a marker of risk. Cue-induced craving Elsevier Buprenorphine Elsevier Craving Elsevier Prescription opioids Elsevier Fitzmaurice, Garrett M. oth Carroll, Kathleen M. oth Griffin, Margaret L. oth Hill, Kevin P. oth Wasan, Ajay D. oth Weiss, Roger D. oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:145 year:2014 day:1 month:12 pages:121-126 extent:6 https://doi.org/10.1016/j.drugalcdep.2014.10.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 145 2014 1 1201 121-126 6 045F 610 |
allfieldsSound |
10.1016/j.drugalcdep.2014.10.002 doi GBVA2014012000016.pica (DE-627)ELV017546443 (ELSEVIER)S0376-8716(14)01847-X DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl McHugh, R. Kathryn verfasserin aut Assessing craving and its relationship to subsequent prescription opioid use among treatment-seeking prescription opioid dependent patients 2014 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Drug craving predicts future drug use, especially in the short term. • A 3-item measure predicted prescription opioid use in the next week. • For each 1 unit increase on the scale, the odds of using opioid was 17% higher. • Brief assessment of prescription opioid craving may provide a marker of risk. Cue-induced craving Elsevier Buprenorphine Elsevier Craving Elsevier Prescription opioids Elsevier Fitzmaurice, Garrett M. oth Carroll, Kathleen M. oth Griffin, Margaret L. oth Hill, Kevin P. oth Wasan, Ajay D. oth Weiss, Roger D. oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:145 year:2014 day:1 month:12 pages:121-126 extent:6 https://doi.org/10.1016/j.drugalcdep.2014.10.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 145 2014 1 1201 121-126 6 045F 610 |
language |
English |
source |
Enthalten in Statistical analysis to identify biomarkers for safety Amsterdam [u.a.] volume:145 year:2014 day:1 month:12 pages:121-126 extent:6 |
sourceStr |
Enthalten in Statistical analysis to identify biomarkers for safety Amsterdam [u.a.] volume:145 year:2014 day:1 month:12 pages:121-126 extent:6 |
format_phy_str_mv |
Article |
bklname |
Pharmakologie Toxikologie |
institution |
findex.gbv.de |
topic_facet |
Cue-induced craving Buprenorphine Craving Prescription opioids |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
Statistical analysis to identify biomarkers for safety |
authorswithroles_txt_mv |
McHugh, R. Kathryn @@aut@@ Fitzmaurice, Garrett M. @@oth@@ Carroll, Kathleen M. @@oth@@ Griffin, Margaret L. @@oth@@ Hill, Kevin P. @@oth@@ Wasan, Ajay D. @@oth@@ Weiss, Roger D. @@oth@@ |
publishDateDaySort_date |
2014-01-01T00:00:00Z |
hierarchy_top_id |
ELV000553670 |
dewey-sort |
3610 |
id |
ELV017546443 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV017546443</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623135328.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.drugalcdep.2014.10.002</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014012000016.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV017546443</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0376-8716(14)01847-X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">15,3</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PHARM</subfield><subfield code="q">DE-84</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.38</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.39</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">McHugh, R. Kathryn</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Assessing craving and its relationship to subsequent prescription opioid use among treatment-seeking prescription opioid dependent patients</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Drug craving predicts future drug use, especially in the short term. • A 3-item measure predicted prescription opioid use in the next week. • For each 1 unit increase on the scale, the odds of using opioid was 17% higher. • Brief assessment of prescription opioid craving may provide a marker of risk.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cue-induced craving</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Buprenorphine</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Craving</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Prescription opioids</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fitzmaurice, Garrett M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Carroll, Kathleen M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Griffin, Margaret L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hill, Kevin P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wasan, Ajay D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Weiss, Roger D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Clark, Matthew ELSEVIER</subfield><subfield code="t">Statistical analysis to identify biomarkers for safety</subfield><subfield code="d">2018</subfield><subfield code="d">an international journal on biomedical and psychosocial approaches</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000553670</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:145</subfield><subfield code="g">year:2014</subfield><subfield code="g">day:1</subfield><subfield code="g">month:12</subfield><subfield code="g">pages:121-126</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.drugalcdep.2014.10.002</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-PHARM</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.38</subfield><subfield code="j">Pharmakologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.39</subfield><subfield code="j">Toxikologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">145</subfield><subfield code="j">2014</subfield><subfield code="b">1</subfield><subfield code="c">1201</subfield><subfield code="h">121-126</subfield><subfield code="g">6</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
author |
McHugh, R. Kathryn |
spellingShingle |
McHugh, R. Kathryn ddc 610 ssgn 15,3 fid PHARM bkl 44.38 bkl 44.39 Elsevier Cue-induced craving Elsevier Buprenorphine Elsevier Craving Elsevier Prescription opioids Assessing craving and its relationship to subsequent prescription opioid use among treatment-seeking prescription opioid dependent patients |
authorStr |
McHugh, R. Kathryn |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000553670 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Assessing craving and its relationship to subsequent prescription opioid use among treatment-seeking prescription opioid dependent patients Cue-induced craving Elsevier Buprenorphine Elsevier Craving Elsevier Prescription opioids Elsevier |
topic |
ddc 610 ssgn 15,3 fid PHARM bkl 44.38 bkl 44.39 Elsevier Cue-induced craving Elsevier Buprenorphine Elsevier Craving Elsevier Prescription opioids |
topic_unstemmed |
ddc 610 ssgn 15,3 fid PHARM bkl 44.38 bkl 44.39 Elsevier Cue-induced craving Elsevier Buprenorphine Elsevier Craving Elsevier Prescription opioids |
topic_browse |
ddc 610 ssgn 15,3 fid PHARM bkl 44.38 bkl 44.39 Elsevier Cue-induced craving Elsevier Buprenorphine Elsevier Craving Elsevier Prescription opioids |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
g m f gm gmf k m c km kmc m l g ml mlg k p h kp kph a d w ad adw r d w rd rdw |
hierarchy_parent_title |
Statistical analysis to identify biomarkers for safety |
hierarchy_parent_id |
ELV000553670 |
dewey-tens |
610 - Medicine & health |
hierarchy_top_title |
Statistical analysis to identify biomarkers for safety |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV000553670 |
title |
Assessing craving and its relationship to subsequent prescription opioid use among treatment-seeking prescription opioid dependent patients |
ctrlnum |
(DE-627)ELV017546443 (ELSEVIER)S0376-8716(14)01847-X |
title_full |
Assessing craving and its relationship to subsequent prescription opioid use among treatment-seeking prescription opioid dependent patients |
author_sort |
McHugh, R. Kathryn |
journal |
Statistical analysis to identify biomarkers for safety |
journalStr |
Statistical analysis to identify biomarkers for safety |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology |
recordtype |
marc |
publishDateSort |
2014 |
contenttype_str_mv |
zzz |
container_start_page |
121 |
author_browse |
McHugh, R. Kathryn |
container_volume |
145 |
physical |
6 |
class |
610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
McHugh, R. Kathryn |
doi_str_mv |
10.1016/j.drugalcdep.2014.10.002 |
dewey-full |
610 |
title_sort |
assessing craving and its relationship to subsequent prescription opioid use among treatment-seeking prescription opioid dependent patients |
title_auth |
Assessing craving and its relationship to subsequent prescription opioid use among treatment-seeking prescription opioid dependent patients |
abstract |
• Drug craving predicts future drug use, especially in the short term. • A 3-item measure predicted prescription opioid use in the next week. • For each 1 unit increase on the scale, the odds of using opioid was 17% higher. • Brief assessment of prescription opioid craving may provide a marker of risk. |
abstractGer |
• Drug craving predicts future drug use, especially in the short term. • A 3-item measure predicted prescription opioid use in the next week. • For each 1 unit increase on the scale, the odds of using opioid was 17% higher. • Brief assessment of prescription opioid craving may provide a marker of risk. |
abstract_unstemmed |
• Drug craving predicts future drug use, especially in the short term. • A 3-item measure predicted prescription opioid use in the next week. • For each 1 unit increase on the scale, the odds of using opioid was 17% higher. • Brief assessment of prescription opioid craving may provide a marker of risk. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA |
title_short |
Assessing craving and its relationship to subsequent prescription opioid use among treatment-seeking prescription opioid dependent patients |
url |
https://doi.org/10.1016/j.drugalcdep.2014.10.002 |
remote_bool |
true |
author2 |
Fitzmaurice, Garrett M. Carroll, Kathleen M. Griffin, Margaret L. Hill, Kevin P. Wasan, Ajay D. Weiss, Roger D. |
author2Str |
Fitzmaurice, Garrett M. Carroll, Kathleen M. Griffin, Margaret L. Hill, Kevin P. Wasan, Ajay D. Weiss, Roger D. |
ppnlink |
ELV000553670 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth oth oth |
doi_str |
10.1016/j.drugalcdep.2014.10.002 |
up_date |
2024-07-06T16:35:56.874Z |
_version_ |
1803848260648960000 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV017546443</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623135328.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.drugalcdep.2014.10.002</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014012000016.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV017546443</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0376-8716(14)01847-X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">15,3</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PHARM</subfield><subfield code="q">DE-84</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.38</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.39</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">McHugh, R. Kathryn</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Assessing craving and its relationship to subsequent prescription opioid use among treatment-seeking prescription opioid dependent patients</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Drug craving predicts future drug use, especially in the short term. • A 3-item measure predicted prescription opioid use in the next week. • For each 1 unit increase on the scale, the odds of using opioid was 17% higher. • Brief assessment of prescription opioid craving may provide a marker of risk.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cue-induced craving</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Buprenorphine</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Craving</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Prescription opioids</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fitzmaurice, Garrett M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Carroll, Kathleen M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Griffin, Margaret L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hill, Kevin P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wasan, Ajay D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Weiss, Roger D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Clark, Matthew ELSEVIER</subfield><subfield code="t">Statistical analysis to identify biomarkers for safety</subfield><subfield code="d">2018</subfield><subfield code="d">an international journal on biomedical and psychosocial approaches</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000553670</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:145</subfield><subfield code="g">year:2014</subfield><subfield code="g">day:1</subfield><subfield code="g">month:12</subfield><subfield code="g">pages:121-126</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.drugalcdep.2014.10.002</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-PHARM</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.38</subfield><subfield code="j">Pharmakologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.39</subfield><subfield code="j">Toxikologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">145</subfield><subfield code="j">2014</subfield><subfield code="b">1</subfield><subfield code="c">1201</subfield><subfield code="h">121-126</subfield><subfield code="g">6</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
score |
7.399102 |